The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1)

Molecular Immunology

Volumn 42, Issue 6, 2005, Pages 657-663

  Windfuhr, Jochen P ^a,c   Alsenz, Jochem ^b   Loos, Michael ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c St Anna Hospital   (Germany)

Author keywords

C1 esterase inhibitor; Complement; Control of C1 auto activation; Monoclonal antibodies against C1 INH

Indexed keywords

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; COMPLEMENT ACTIVATION; CONCENTRATION RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOLYSIS; INHIBITION KINETICS; PRIORITY JOURNAL; SERODIAGNOSIS; SERUM;

EID: 15244350140     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.09.025     Document Type: Article

References (35)

1. J. Alsenz, K. Bork, and M. Loos Autoantibody-mediated acquired deficiency of C1-inhibitor N. Engl. J. Med. 316 1987 1360 1366 316, 1360-1366
2. J. Alsenz, J.D. Lambris, K. Bork, and M. Loos Acquired C1-inhibitor (C1-INH) deficiency type II J. Clin. Invest. 83 1989 1794 1799
3. J. Alsenz, and M. Loos Simplified methods for the purification, quantitation, and functional estimation of human complement C1-inhibitor (C1-INH) with a monoclonal anti-C1-INH antibody J. Immunol. Methods 96 1987 107 114
4. J. Alsenz, and M. Loos The acquired C1-INH deficiencies with autoantibodies (AAE type II) Behring Inst. Mitteilungen 84 1989 165 172
5. K. Bork, J. Alsenz, M. Bockers, E. Noah, and M. Loos IgG- Antikörperbildung gegen C1-Inhibitor als Ursache lebensbedrohlicher Angioödeme Dtsch. Med. Wschr. 112 1987 503 506
6. C. Caliezi, W.A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C.E. Hack C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema Pharmacol. Rev. 52 2000 91 112
7. M. Cicardi, L. Bergamaschini, M. Cugno, A. Beretta, L.C. Zingale, M. Colombo, and A. Agostoni Pathogenectic and clinical aspects of C1 inhibitor deficiency Immunobiology 199 1998 366 376
8. A.E. Davis Structure and function of C1-inhibitor Behring Inst. Mitteilungen 84 1989 142 150
9. A.E. Davis III, J.J. Bissler, and M. Cicardi Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema Behring Inst. Mitteilungen 93 1993 313 320
10. V.H. Donaldson C1-inhibitor in hereditary angioneurotic edema: types I and II Behring Inst. Mitteilungen 84 1989 151 160
11. V.H. Donaldson, R.A. Harrison, F.S. Rosen, D.H. Bing, G. Kindness, J. Canar, C.J. Wagner, and S. Awad Variability in purified dysfunctional C1-inhibitor proteins from patients with hereditary angioedema Functional and analytical gel studies J. Clin. Invest. 75 1985 124 132
12. R.S. Geha, I. Quinti, K.F. Austen, M. Cicardi, A. Sheffer, and F.S. Rosen Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins N. Engl. J. Med. 316 1987 1360 1366 312, 534-540
13. B. Ghebrehiwet, B.P. Randazzo, and A.P. Kaplan Studies of complement autoactivity in hereditary angioedema: direct relationship to functional C1-inactivator and the effect of classical pathway activators Clin. Immunol. Immunpathol. 32 1984 101 110
14. H.P.T.H. Heinz, M. Latsch, and M. Loos Vereinfachter Mikroassay zur Bestimmung der gesamthämolytischen Komplementaktivität, CH-50 Lab. Med. 9 1985 320
15. S. Hosoi, A. Circolo, and T. Borsos Activation of human C1: analysis with western blotting reveals slow-auto-activation J. Immunol. 139 1987 1602 1608
16. N.S. Landermann, M.E. Webster, and E.L. Becker Hereditary angioneurotic edema II. Deficiency of inhibitor for serum globulin permeability factor and for plasma and for plasma kallikrein J. Allergy 33 1962 330
17. I.H. Lepow, O.D. Ratnoff, and L.R. Levy Studies on the activation of a proesterase associated with partially purified first component of human complement J. Exp. Med. 107 1958 451 474
18. I.H. Lepow, O.D. Ratnoff, F. Rosen, and L. Pillemer Oberservation on a proesterase associated with partially purified first component of human complement Proc. Soc. Exp. Biol. Med. 92 1956 32 37
19. M. Loos, T. Borsos, and H.J. Rapp Activation of the first component of complement in serum: evidence for an internal activation step J. Immunol. 108 1972 683 688
20. J. Melamed, C.A. Alper, M. Cicardi, and F.S. Rosen The metabolism of C1-inhibitor and C1q in patients with acquired C1-inhibitor deficiency J. Allergy Clin. Immunol. 77 1986 322 326
21. T. Nilsson, and O. Back Elevated plasmin-a2-antiplasmin complex levels in hereditary angioedema: evidence for the in vivo efficiency of the intrinsic fibrinolytic system Thromb. Res. 40 1985 817 821
22. Opferkuch, W., Echternacht, K., Gronemeyer, W., Hammar, C., Jaeger, J., Nieczyk, H., Rieger, C., 1980. Klinische Ausprägung und Therapie des hereditären angioneurotischen Ödems (HANE). G. Witzstrock Verlag, Baden-Baden.
23. W. Osler Hereditary angioneurotic edema Am. J. Med. Sci. 95 1988 362
24. V.H. Quincke Über akutes umschriebenes Hautödem Mschr. Prakt. Derm. 1 1882 129
25. H.J. Rapp, and T. Borsos Molecular basis of complement action 1970 Appleton-Century-Crofts. Meredith Corp. New York, NY
26. R. Ringelmann, W. Opferkuch, M. Röllinghoff, and M. Loos Titration of complement and complement components with a microliter method Z. Med. Mikrobiol. Immunol. 154 1969 329 338
27. K. Sayama, S. Shiraishi, and Y. Miki Complement profile in a C1-inhibitor deficient family Br. J. Dermatol. 113 1985 737 743
28. M. Schapira, A. de Agostini, J.A. Schifferli, and R.W. Colman Biochemistry and pathophysiology of human C1-Inhibitor: current issues Complement 2 1985 111 126
29. F. Schindera Hereditäres angioneurotisches Ödem durch funktionell inaktiven C1-esterase-inhibitor Die gelben Hefte 2 1988 81
30. V.N. Schumaker, Y. Tseng, P.H. Poon, A.C. Bianchino, and P. Zavodsky Spontaneous activation of reconstituted and serum C1 and the role of C1-inhibitor Behring Inst. Mitteilungen 84 1984 102
31. A.L. Sheffer, D.T. Fearon, and K.F. Austen Hereditary angioedema: a decade of management with stanazol J. Allergy Clin. Immunol. 80 1987 855 860
32. P.J. Spaeth, B. Wuethrich, L. Matter, M. Loos, and J. Alsenz Acquired angioedema and anti-C1-inhibitor autoantibody Behring Inst. Mitteilungen 84 1989 201 202
33. D. Storm, M. Loos, and M. Kaul Biotinylation of proteins via amino groups can induce binding to U937 cells, HL-60 cells, monocytes and granulosystes J. Immunol. Methods 199 1996 87 99
34. R.J. Ziccardi Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism J. Immunol. 128 1982 2500 2504
35. R.J. Ziccardi The first component of complement (C1): activation and control Springer Semin. Immunopathol. 6 1983 213 230